NCT01200264View on ClinicalTrials.gov

Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

September 30, 2012

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

apremilast

apremilast 10 mg tablets with dose titration to 30 mg BID for 169 days

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER